BioLife4D Corporation (SAVU)

BioLife4D Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	-	0.99	0.9
Research & Development	-	0.78	0.68
Other Operating Expenses	0	0.01	0.01
Operating Expenses	-	1.78	1.59
Operating Income	-2.25	-1.78	-1.59
Interest Expense / Income	0.11	0.11	0.12
Other Expense / Income	-0.4	-0.4	-
Pretax Income	-1.96	-1.5	-1.7
Net Income	-1.96	-1.5	-1.7
Free Cash Flow	-1.22	-1.12	-1.47
EBITDA	-1.84	-1.38	-1.58
Depreciation & Amortization	0.01	0.01	0.01
EBIT	-1.85	-1.38	-1.59

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).